Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease

ISSN： 1460-2156

Source： Brain, Vol.132, Iss.6, 2009-06, pp. : 1545-1552

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

McArdle's Disease

PRACTICAL NEUROLOGY, Vol. 1, Iss. 2, 2001-12 ,pp. : 122-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of spectrum and frequencies of mutations in McArdle disease: Identification of 13 novel mutations

By Deschauer M. Morgenroth A. Joshi P. Gläser D. Chinnery P. Aasly J. Schreiber H. Knape M. Zierz S. Vorgerd M.

Journal of Neurology, Vol. 254, Iss. 6, 2007-06 ,pp. : 797-802

Springer Publishing Company

Access to resources Recommend Favorite

Spotlight on skeletal muscle disorders: from ribonuclear inclusion in myotonic dystrophy to treatment of McArdle’s Disease by oral sucrose

By Strupp Michael

Journal of Neurology, Vol. 251, Iss. 2, 2004-02 ,pp. : 242-244

Springer Publishing Company

Access to resources Recommend Favorite

RNA-targeted splice-correction therapy for neuromuscular disease

By Wood Matthew J. A.

Brain, Vol. 133, Iss. 4, 2010-04 ,pp. : 957-972

Oxford University Press

Access to resources Recommend Favorite

The neuropathology and clinical phenotype of FTD with progranulin mutations

By Mackenzie Ian

Acta Neuropathologica, Vol. 114, Iss. 1, 2007-07 ,pp. : 49-54

Springer Publishing Company

Access to resources Recommend Favorite